title: Embracing diversity in remodeling: a step in therapeutic decision making in heart failure?
authors.forename: Yellaprada
authors.initials: Y
authors.lastname: Chandrashekhar
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001794:Blood Pressure; D001810:Blood Volume; D001920:Bradykinin / Q000378:metabolism; D003657:Decision Making; D005355:Fibrosis / Q000188:drug therapy / Q000473:pathology; D006333:Heart Failure / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000473:pathology; D020257:Ventricular Remodeling / Q000187:drug effects
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D020782:Matrix Metalloproteinases; D001920:Bradykinin